US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scinai Immunotherapeutics Ltd.

2.55

-0.7000-21.54%

Post-market: 2.47-0.0800-3.14%19:55 EDT

Volume:642.70K

Turnover:1.69M

Market Cap:2.55M

PE:0.31

High:3.12

Open:3.11

Low:2.23

Close:3.25

Loading ...

Overview Company News Filings

ADRs Advance; Scinai Immunotherapeutics Ltd. Climbs 29%

BUZZ-Scinai more than doubles after Italian approval for biotech acquisition

Scinai Immunotherapeutics 2024 Revenue $658K

Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases

Scinai Immunotherapeutics Signs Option Deal to Acquire Italy's Pincell

MT Newswires Live

Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions

Scinai Immunotherapeutics announces $10M standby equity purchase agreement

Press Release: SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT

Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SCNI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCNI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNI\",,,,,undefined,":{"symbol":"SCNI","market":"US","secType":"STK","nameCN":"Scinai Immunotherapeutics Ltd.","latestPrice":2.55,"timestamp":1749240000000,"preClose":3.25,"halted":0,"volume":642698,"hourTrading":{"tag":"盘后","latestPrice":2.47,"preClose":2.55,"latestTime":"19:55 EDT","volume":15979,"amount":40139.457,"timestamp":1749254105802},"delay":0,"floatShares":677000,"shares":999918,"eps":8.202362,"marketStatus":"Market Closed","change":-0.7,"latestTime":"06-06 16:00:00 EDT","open":3.11,"high":3.1199,"low":2.23,"amount":1685288.0942632,"amplitude":0.273815,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":8.202362,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"adrRate":4000,"listingDate":1431403200000,"exchange":"NASDAQ","adjPreClose":3.25,"preHourTrading":{"tag":"盘前","latestPrice":3.054,"preClose":3.25,"latestTime":"09:29 EDT","volume":22764,"amount":64988.6203512,"timestamp":1749216587457},"postHourTrading":{"tag":"盘后","latestPrice":2.47,"preClose":2.55,"latestTime":"19:55 EDT","volume":15979,"amount":40139.457,"timestamp":1749254105802},"volumeRatio":0.15635091257745012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNI\",,,,,undefined,":{"symbol":"SCNI","floatShares":677000,"roa":"-34.92%","roe":"177.37%","lyrEps":-16.638636,"volumeRatio":0.15635091257745012,"shares":999918,"dividePrice":0,"high":3.1199,"amplitude":0.273815,"preClose":3.25,"low":2.23,"week52Low":1.9,"pbRate":"0.59","psRate":"3.88","week52High":8.92,"institutionHeld":0,"latestPrice":2.55,"eps":8.202362,"divideRate":0,"volume":642698,"delay":0,"ttmEps":8.202362,"open":3.11,"prevYearClose":3.345,"prevWeekClose":2.72,"prevMonthClose":2.72,"prevQuarterClose":2.6939,"fiveDayClose":2.72,"twentyDayClose":2.8,"sixtyDayClose":3.4004},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCNI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541005041","title":"ADRs Advance; Scinai Immunotherapeutics Ltd. Climbs 29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541005041","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541005041?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:30","pubTimestamp":1749155400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed higher on Thursday, as the S&P/BNY Mellon index of American depositary receipts increased 0.3% to 199.84.The European index added 0.4% to 184.78. The Asian index gained 0.2% to 254.01. The Latin American index increased 0.6% to 198.77, while the emerging-markets index rose 0.5% to 410.78.Israel's Scinai Immunotherapeutics Ltd. was the biggest leader during the session, soaring 29% to $3.25, and China-based I-Mab rocketed 28% to $2.29. IperionX Ltd., which is based in Australia, rounded out the top three leaders on Thursday, with shares jumping 20% to $29.24.NuCana PLC, based in United Kingdom, posted the largest decline, plunging 14% to 4 cents, followed by shares of China's Chagee Holdings Ltd., which dropped 9.8% to $31.66. Shares of China-based ATA Creativity Global dropped 9.3% to 80 cents.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"ADRs Advance; Scinai Immunotherapeutics Ltd. Climbs 29%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","SCNI"],"gpt_icon":0},{"id":"2541076576","title":"BUZZ-Scinai more than doubles after Italian approval for biotech acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2541076576","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541076576?lang=en_us&edition=fundamental","pubTime":"2025-06-05 22:04","pubTimestamp":1749132295,"startTime":"0","endTime":"0","summary":"BUZZ-Scinai more than doubles after Italian approval for biotech acquisition** U.S.-listed shares of Scinai Immunotherapeutics 2F5y.F, SCNI.O rise 104% to $5.15** Stock set for its best day on record, if gains hold** Co says it received Italian government's clearance to potentially acquire Italian biotech firm Pincell, which is developing novel antibody to treat severe skin conditions** Approval removes major regulatory hurdle for acquisition but does not finalize deal, SCNI says** Scinai plans to acquire 100% of Pincell's share capital and voting rights** Acquisition, initially agreed in March, still requires meeting additional conditions before completion, co says** Pincell's lead drug, antibody PC111, is being developed to treat rare and severe skin disorders** Including session's moves, SCNI up 54.3% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nL3N3S8101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","SCNI"],"gpt_icon":0},{"id":"2533586962","title":"Scinai Immunotherapeutics 2024 Revenue $658K","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586962","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586962?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:54","pubTimestamp":1746651252,"startTime":"0","endTime":"0","summary":"Scinai Immunotherapeutics 2024 Revenue $658K","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45268974/scinai-immunotherapeutics-2024-revenue-658k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNI"],"gpt_icon":0},{"id":"2532097071","title":"Scinai Immunotherapeutics and Pincell to Host Webinar on a Blockbuster Drug Candidate for Devastating Rare Skin Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2532097071","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532097071?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:00","pubTimestamp":1746097200,"startTime":"0","endTime":"0","summary":"The webinar will explore PC111, a novel monoclonal antibody drug candidate with the potential to transform the treatment landscape forPemphigus Vulgaris and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis .JERUSALEM, Israel, May 1, 2025 /PRNewswire/ --Scinai Immunotherapeutics Ltd. , a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and which provides CDMO services through its Scinai Bioservices unit, today announced that it will be hosting a webinar on Wednesday May 7th at, at 11:30 AM EST / 18:30 Israel time. The webinar will address the unmet needs in treating Pemphigus Vulgaris and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis  and explore Pincell's PC111, a novel monoclonal antibody targeting soluble Fas ligand  as a promising solution.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/scinai-immunotherapeutics-pincell-host-webinar-110000506.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scinai-immunotherapeutics-pincell-host-webinar-110000506.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","FENG","SCNI","BK4124","TEN","BK4218","BK4077","HST","BK4007","BK4585","BK4144","BK4588","BK4181"],"gpt_icon":0},{"id":"2522008623","title":"Scinai Immunotherapeutics Signs Option Deal to Acquire Italy's Pincell","url":"https://stock-news.laohu8.com/highlight/detail?id=2522008623","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522008623?lang=en_us&edition=fundamental","pubTime":"2025-03-27 22:43","pubTimestamp":1743086632,"startTime":"0","endTime":"0","summary":"Scinai Immunotherapeutics  said Thursday it signed a binding option agreement to acquire Italian biotech firm Pincell by the end of the year.Pincell's PC111 product candidate is under development for the treatment of Pemphigus, Steven Johnson's Syndrome, and Toxic Epidermal Necrolysis. Scinai said PC111 has the potential for accelerated approval given the severity of these diseases and its non-immunosuppressive mechanism of action.To facilitate a grant application, Pincell exclusively licensed PC111 to Scinai's wholly owned Polish subsidiary, which submitted an application under the European Funds for a Modern Economy program in Poland. Scinai is seeking 12 million euros  in non-dilutive funding for PC111's development.If Scinai exercises the option to acquire Pincell, the Italian company's shareholders will be eligible for milestone payments and royalties on future net sales of PC111 in the low single digits.The financial terms of the option agreement were not disclosed.Shares of Scin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","SCNI","BK4139"],"gpt_icon":0},{"id":"2522304467","title":"Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2522304467","media":"PR Newswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522304467?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:25","pubTimestamp":1743081900,"startTime":"0","endTime":"0","summary":"Scinai files an application for Euro 12 million grant to fund next stage of development. Pincell's monoclonal antibody, PC111, is in development for treating Pemphigus, Steven Johnson's Syndrome  and Toxic Epidermal Necrolysis . PC111 has already received an Orphan Drug Designation inPemphigus by the European Medicine's Agency. An application will be filed with the FDA for Orphan Drug and Breakthrough Designation inPemphigus, as well as in SJS/TEN. Scinai sees potential for accelerated approval given the severity of these diseases, PC111's innovative, non-immunosuppressive mode of action and the lack of effective alternative treatments. Pincell has carried out a large number of in-vitro, ex-vivo and in-vivo experiments using PC111 without steroids in validated models of pemphigus, to prove that soluble FasL is a critical target in this disease. Most importantly, Pincell has demonstrated that PC111 can block blister formation without steroids in a transgenic humanized FasL mouse model o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/scinai-signs-option-agreement-acquire-132500392.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scinai-signs-option-agreement-acquire-132500392.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4124","TEN","BK4077","FENG","SCNI","BK4144","BK4007","BK4139"],"gpt_icon":0},{"id":"2517916196","title":"Scinai Immunotherapeutics announces $10M standby equity purchase agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916196","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517916196?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:37","pubTimestamp":1741178256,"startTime":"0","endTime":"0","summary":"Scinai Immunotherapeutics (SCNI) announced that it has entered into a Standby Equity Purchase Agreement with YA II PN, Ltd., a fund managed by York...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scinai-immunotherapeutics-announces-10m-standby-equity-purchase-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scinai-immunotherapeutics-announces-10m-standby-equity-purchase-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SCNI","BK4007"],"gpt_icon":0},{"id":"2517916988","title":"Press Release: SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916988","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517916988?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:30","pubTimestamp":1741177800,"startTime":"0","endTime":"0","summary":"JERUSALEM, March 5, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd.  , a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, announced that it has entered into a Standby Equity Purchase Agreement  with YA II PN, Ltd. , a fund managed by Yorkville Advisors Global, LP.Under the terms of the SEPA, Scinai has the right, but not the obligation, to sell up to $10 million  of its American Depository Shares , each representing 4,000 ordinary shares, to Yorkville at any time during the three-year period following the execution date of the SEPA and following the effectiveness of a registration statement filed with the Securities and Exchange Commission registering the ordinary shares represented by the ADSs issuable pursuant to the SEPA. Sales to Yorkville under the SEPA are subject to a beneficial ownership cap of 9.99% of Scinai's share capital at any one time, along ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4007","BK4588","BK4215","SCNI","EQR"],"gpt_icon":0},{"id":"2501236166","title":"Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2501236166","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501236166?lang=en_us&edition=fundamental","pubTime":"2025-01-06 20:30","pubTimestamp":1736166600,"startTime":"0","endTime":"0","summary":"JERUSALEM, Jan. 6, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd.  , a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and offering CDMO services through its Scinai Bioservices unit, announced today that its CEO, Mr. Amir Reichman, and Chairman of the Board, Mr. Mark Germain, will attend the IATI Mini Mixiii Conference in Miami, FL on Jan 9, 2025 and the JP Morgan HealthCare Conference week in San Francisco from Jan 13-15, 2025. On Jan 14, 2025, Mr. Reichman and Mr. Germain will also participate in the SIC Biotech Symposium in San Francisco.Institutional and private investors interested in Scinai's value proposition.Potential pharma partners in the inflammation & immunology field interested in co-developing or in-licensing Scinai's innovative NanoAbs.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/scinai-connect-investors-pharma-leaders-123000041.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scinai-connect-investors-pharma-leaders-123000041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","SCNI","ISBC","BK4139","BK4211"],"gpt_icon":0},{"id":"2491405618","title":"Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2491405618","media":"PR Newswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491405618?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:25","pubTimestamp":1734359100,"startTime":"0","endTime":"0","summary":"JERUSALEM, Dec. 16, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd.  , a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, announced today the establishment of a U.S.-based subsidiary for its Contract Development and Manufacturing Services. The new subsidiary, incorporated in Delaware, will operate under the name Scinai Bioservices Inc.In 2024, Scinai launched its CDMO business unit, branded as Scinai Bioservices, operating from the Company's site in Jerusalem, Israel. This facility includes 1,850 square meters  of clean rooms and laboratories, all operating under cGMP conditions in compliance with European Medicines Agency  and FDA requirements.Scinai's new U.S. subsidiary, Scinai Bioservices Inc., aims to serve U.S.-based early-stage biotech companies by providing the required CDMO services that are currently in short supply. This is coupled with growing d","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/NwNW45kpBFBmBXlHa8cj0A--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/8865f453b326692174ace4c4e2150008","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/NwNW45kpBFBmBXlHa8cj0A--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/8865f453b326692174ace4c4e2150008"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/scinai-immunotherapeutics-establishes-u-subsidiary-142500378.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scinai-immunotherapeutics-establishes-u-subsidiary-142500378.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SCNI","BK4007","CDMO","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCNI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-21","symbol":"SCNI","defaultRemindTime":1716298200000,"type":"split","dateTimestamp":1716264000000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCNI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCNI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCNI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCNI","date":"2025-06-06","current":0.632706,"percent":0.93932,"low":-2.685473,"twenty":-0.479207,"median":-0.237682,"eighty":0.589068,"high":0.712948,"avg":-0.109684,"sd":0.523784,"marketCap":3034456},"quantilePoints":[{"date":"2023-09-15","current":-0.556301,"twenty":-0.631114,"median":-0.628237,"eighty":-0.610051,"marketCap":4236234},{"date":"2023-09-22","current":-0.494851,"twenty":-0.629196,"median":-0.556301,"eighty":-0.484902,"marketCap":3768291},{"date":"2023-09-29","current":-0.462925,"twenty":-0.625388,"median":-0.490861,"eighty":-0.469979,"marketCap":3525175},{"date":"2023-10-06","current":-0.372469,"twenty":-0.583176,"median":-0.478888,"eighty":-0.458668,"marketCap":2836348},{"date":"2023-10-13","current":-0.345864,"twenty":-0.541747,"median":-0.469112,"eighty":-0.399372,"marketCap":2633751},{"date":"2023-10-20","current":-0.402851,"twenty":-0.509729,"median":-0.462925,"eighty":-0.399052,"marketCap":3067713},{"date":"2023-10-27","current":-0.345864,"twenty":-0.494851,"median":-0.452283,"eighty":-0.398967,"marketCap":2633751},{"date":"2023-11-03","current":-0.305443,"twenty":-0.48687,"median":-0.415808,"eighty":-0.351185,"marketCap":2836348},{"date":"2023-11-10","current":-0.307765,"twenty":-0.47942,"median":-0.402851,"eighty":-0.329954,"marketCap":2857909},{"date":"2023-11-17","current":-0.290566,"twenty":-0.478888,"median":-0.399046,"eighty":-0.304625,"marketCap":2698194},{"date":"2023-11-24","current":-0.280724,"twenty":-0.471761,"median":-0.396359,"eighty":-0.296716,"marketCap":2606803},{"date":"2023-12-01","current":-0.336963,"twenty":-0.469979,"median":-0.372469,"eighty":-0.295253,"marketCap":3129034},{"date":"2023-12-08","current":-0.345586,"twenty":-0.468593,"median":-0.345936,"eighty":-0.296423,"marketCap":3209110},{"date":"2023-12-15","current":-0.356177,"twenty":-0.463989,"median":-0.345864,"eighty":-0.296716,"marketCap":3307463},{"date":"2023-12-22","current":-0.323372,"twenty":-0.462925,"median":-0.342844,"eighty":-0.300207,"marketCap":3002828},{"date":"2023-12-29","current":-0.328011,"twenty":-0.458668,"median":-0.338946,"eighty":-0.298462,"marketCap":3045913},{"date":"2024-01-05","current":-0.288691,"twenty":-0.452283,"median":-0.33762,"eighty":-0.295721,"marketCap":2680786},{"date":"2024-01-12","current":-0.269476,"twenty":-0.425678,"median":-0.329954,"eighty":-0.292353,"marketCap":2502357},{"date":"2024-01-19","current":-0.248387,"twenty":-0.424827,"median":-0.328058,"eighty":-0.28754,"marketCap":2306520},{"date":"2024-01-26","current":-0.2437,"twenty":-0.410524,"median":-0.328058,"eighty":-0.280724,"marketCap":2263001},{"date":"2024-02-02","current":-0.220736,"twenty":-0.404873,"median":-0.328011,"eighty":-0.276506,"marketCap":2049757},{"date":"2024-02-09","current":-0.234327,"twenty":-0.403149,"median":-0.31824,"eighty":-0.271351,"marketCap":2175963},{"date":"2024-02-16","current":-0.239014,"twenty":-0.400255,"median":-0.308843,"eighty":-0.261509,"marketCap":2219482},{"date":"2024-02-23","current":-0.234327,"twenty":-0.399286,"median":-0.305443,"eighty":-0.25163,"marketCap":2175963},{"date":"2024-03-01","current":-0.230062,"twenty":-0.399041,"median":-0.302852,"eighty":-0.241826,"marketCap":2136360},{"date":"2024-03-08","current":-0.234327,"twenty":-0.398988,"median":-0.296716,"eighty":-0.234778,"marketCap":2175963},{"date":"2024-03-15","current":-0.234327,"twenty":-0.395838,"median":-0.295253,"eighty":-0.234749,"marketCap":2175963},{"date":"2024-03-22","current":-0.2437,"twenty":-0.381301,"median":-0.292353,"eighty":-0.234327,"marketCap":2263001},{"date":"2024-03-28","current":-0.234327,"twenty":-0.372788,"median":-0.288691,"eighty":-0.234327,"marketCap":2175963},{"date":"2024-04-05","current":-0.220314,"twenty":-0.365952,"median":-0.283466,"eighty":-0.234327,"marketCap":2045840},{"date":"2024-04-12","current":-0.224954,"twenty":-0.35418,"median":-0.280724,"eighty":-0.232875,"marketCap":2088924},{"date":"2024-04-19","current":-0.213706,"twenty":-0.349114,"median":-0.278998,"eighty":-0.229809,"marketCap":1984478},{"date":"2024-04-26","current":-0.210894,"twenty":-0.34595,"median":-0.276506,"eighty":-0.228872,"marketCap":1958366},{"date":"2024-05-03","current":-0.215839,"twenty":-0.345864,"median":-0.27182,"eighty":-0.22621,"marketCap":2004279},{"date":"2024-05-10","current":-0.202037,"twenty":-0.345753,"median":-0.267227,"eighty":-0.225554,"marketCap":1876115},{"date":"2024-05-17","current":-0.210894,"twenty":-0.34478,"median":-0.260103,"eighty":-0.224954,"marketCap":1958366},{"date":"2024-05-24","current":-0.246473,"twenty":-0.34478,"median":-0.25776,"eighty":-0.224954,"marketCap":1602072},{"date":"2024-05-31","current":-0.241029,"twenty":-0.34328,"median":-0.25776,"eighty":-0.224982,"marketCap":1566691},{"date":"2024-06-07","current":-0.27778,"twenty":-0.341484,"median":-0.253412,"eighty":-0.225161,"marketCap":1805568},{"date":"2024-06-14","current":-0.201431,"twenty":-0.338946,"median":-0.252049,"eighty":-0.224954,"marketCap":1309303},{"date":"2024-06-21","current":-0.280004,"twenty":-0.33958,"median":-0.253049,"eighty":-0.224954,"marketCap":1820024},{"date":"2024-06-28","current":-0.204288,"twenty":-0.338719,"median":-0.252049,"eighty":-0.224954,"marketCap":1327875},{"date":"2024-07-05","current":-0.282059,"twenty":-0.337809,"median":-0.253049,"eighty":-0.224954,"marketCap":1450912},{"date":"2024-07-12","current":-0.310491,"twenty":-0.337431,"median":-0.25776,"eighty":-0.224954,"marketCap":1597164},{"date":"2024-07-15","current":-0.366451,"twenty":-0.337733,"median":-0.258765,"eighty":-0.224954,"marketCap":1885025},{"date":"2024-08-02","current":-0.375477,"twenty":-0.338491,"median":-0.259769,"eighty":-0.224954,"marketCap":1931454},{"date":"2024-08-09","current":-0.330348,"twenty":-0.338491,"median":-0.264459,"eighty":-0.224954,"marketCap":1699308},{"date":"2024-08-16","current":-0.85352,"twenty":-0.345753,"median":-0.267227,"eighty":-0.22501,"marketCap":3161439},{"date":"2024-08-23","current":-0.907856,"twenty":-0.350432,"median":-0.271786,"eighty":-0.225226,"marketCap":3362697},{"date":"2024-08-30","current":-0.88748,"twenty":-0.372788,"median":-0.276506,"eighty":-0.225554,"marketCap":3287225},{"date":"2024-09-06","current":-0.803984,"twenty":-0.397924,"median":-0.276506,"eighty":-0.225779,"marketCap":2977958},{"date":"2024-09-13","current":-0.760697,"twenty":-0.399925,"median":-0.277482,"eighty":-0.225891,"marketCap":2817622},{"date":"2024-09-20","current":-0.817296,"twenty":-0.421092,"median":-0.279263,"eighty":-0.225947,"marketCap":3027266},{"date":"2024-09-27","current":-0.937287,"twenty":-0.462925,"median":-0.280724,"eighty":-0.226192,"marketCap":3471712},{"date":"2024-10-04","current":-0.839936,"twenty":-0.477106,"median":-0.281193,"eighty":-0.226275,"marketCap":3111124},{"date":"2024-10-11","current":-0.844464,"twenty":-0.524606,"median":-0.283639,"eighty":-0.226341,"marketCap":3127895},{"date":"2024-10-18","current":-0.821825,"twenty":-0.611001,"median":-0.28799,"eighty":-0.226838,"marketCap":3044038},{"date":"2024-10-25","current":-0.787865,"twenty":-0.630155,"median":-0.291459,"eighty":-0.228623,"marketCap":2918251},{"date":"2024-10-31","current":-0.805977,"twenty":-0.760697,"median":-0.295252,"eighty":-0.229617,"marketCap":2985337},{"date":"2024-11-08","current":-0.792393,"twenty":-0.772017,"median":-0.295721,"eighty":-0.229641,"marketCap":2935023},{"date":"2024-11-15","current":-0.674666,"twenty":-0.772017,"median":-0.298898,"eighty":-0.229641,"marketCap":2498962},{"date":"2024-11-22","current":-0.683722,"twenty":-0.769753,"median":-0.304625,"eighty":-0.229641,"marketCap":2532505},{"date":"2024-11-29","current":0.624851,"twenty":-0.762508,"median":-0.30108,"eighty":-0.229369,"marketCap":2934302},{"date":"2024-12-06","current":0.592156,"twenty":-0.760697,"median":-0.296218,"eighty":-0.226247,"marketCap":2780763},{"date":"2024-12-13","current":0.612136,"twenty":-0.760697,"median":-0.295252,"eighty":-0.225685,"marketCap":2874593},{"date":"2024-12-20","current":0.612136,"twenty":-0.755263,"median":-0.291459,"eighty":-0.224954,"marketCap":2874593},{"date":"2024-12-27","current":0.624851,"twenty":-0.72402,"median":-0.28834,"eighty":-0.224654,"marketCap":2934302},{"date":"2025-01-03","current":0.624851,"twenty":-0.699569,"median":-0.285479,"eighty":-0.22188,"marketCap":2934302},{"date":"2025-01-10","current":0.628484,"twenty":-0.690967,"median":-0.282059,"eighty":-0.220352,"marketCap":2951362},{"date":"2025-01-17","current":0.647557,"twenty":-0.682816,"median":-0.281146,"eighty":-0.220268,"marketCap":3040927},{"date":"2025-01-24","current":0.643379,"twenty":-0.679194,"median":-0.280724,"eighty":-0.215839,"marketCap":3021308},{"date":"2025-01-31","current":0.639383,"twenty":-0.674666,"median":-0.278998,"eighty":-0.213285,"marketCap":3002542},{"date":"2025-02-07","current":0.712948,"twenty":-0.663346,"median":-0.277184,"eighty":-0.210894,"marketCap":3348005},{"date":"2025-02-14","current":0.588523,"twenty":-0.645234,"median":-0.276506,"eighty":-0.20991,"marketCap":2763703},{"date":"2025-02-21","current":0.613154,"twenty":-0.637989,"median":-0.274163,"eighty":-0.20617,"marketCap":2879369},{"date":"2025-02-28","current":0.642398,"twenty":-0.633661,"median":-0.271752,"eighty":-0.203838,"marketCap":3016702},{"date":"2025-03-07","current":0.62031,"twenty":-0.631114,"median":-0.26718,"eighty":-0.192145,"marketCap":2912977},{"date":"2025-03-14","current":0.604871,"twenty":-0.628717,"median":-0.263556,"eighty":0.592156,"marketCap":2840473},{"date":"2025-03-21","current":0.617586,"twenty":-0.624439,"median":-0.258765,"eighty":0.599421,"marketCap":2900183},{"date":"2025-03-28","current":0.526782,"twenty":-0.622773,"median":-0.253073,"eighty":0.601427,"marketCap":2473770},{"date":"2025-04-04","current":0.492252,"twenty":-0.614884,"median":-0.251069,"eighty":0.599756,"marketCap":2311616},{"date":"2025-04-11","current":0.399705,"twenty":-0.612957,"median":-0.249289,"eighty":0.599425,"marketCap":1877015},{"date":"2025-04-17","current":0.348754,"twenty":-0.607088,"median":-0.246473,"eighty":0.599421,"marketCap":1637750},{"date":"2025-04-25","current":0.439576,"twenty":-0.593884,"median":-0.243934,"eighty":0.597242,"marketCap":2064247},{"date":"2025-05-02","current":0.550743,"twenty":-0.568856,"median":-0.2437,"eighty":0.593609,"marketCap":2586290},{"date":"2025-05-09","current":0.5451,"twenty":-0.541747,"median":-0.243232,"eighty":0.592156,"marketCap":2614301},{"date":"2025-05-16","current":0.554834,"twenty":-0.509729,"median":-0.241919,"eighty":0.592156,"marketCap":2660985},{"date":"2025-05-23","current":0.550941,"twenty":-0.490062,"median":-0.240021,"eighty":0.590521,"marketCap":2642311},{"date":"2025-05-30","current":0.523686,"twenty":-0.48389,"median":-0.239014,"eighty":0.589068,"marketCap":2511596},{"date":"2025-06-06","current":0.632706,"twenty":-0.479207,"median":-0.237682,"eighty":0.589068,"marketCap":3034456}],"updateTime":1749296741178}}}